Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CGEN:IT

2,759.00 ILs 18.00 0.65%

As of 10:24:20 ET on 04/27/2015.

Snapshot for Compugen Ltd (CGEN)

Open: 2,777.00 Day's Range: 2,750.00 - 2,815.00 Volume: 49,369
Previous Close: 2,777.00 52wk Range: 2,454.00 - 3,770.00 1-Yr Rtn: -15.68%

Stock Chart for CGEN

No chart data available.
  • CGEN:IT 2,769.00
  • 1D
  • 1M
  • 1Y
2,777.00
Interactive CGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -0.8221
Est. EPS (USD) (12/2015) -0.4930
Est. PEG Ratio -
Market Cap (M ILS) 1,337.54
Shares Outstanding (M) 48.48
30 Day Average Volume 44,465
Price/Book (mrq) 3.3468
Price/Sale (ttm) 30.2382
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CGEN

Compugen Ltd. develops solutions in the field of computational genomics. The Company provides its gene discovery tools to pharmaceutical, biotechnology, and other life sciences through its Web site, labOnWeb.com. Compugen is also seeking to commercialize the genes and proteins it discovers.

Anat Cohen-DayagPresident/CEOAri KrashinChief Financial Officer
John J HunterVP:Antibody Research & DevZurit LevineVP:Research & Discovery
More Company Profile & Key Executives for CGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil